ESR1 and neoplasm: Other demographic and clinical parameters were generally balanced between patients with ESR1 mutations and ESR1 WT patients, including age, race, region, Eastern Cooperative Oncology Group (ECOG) score, baseline tumour burden and others (Supplementary Table 5).